Fisher, M. J., Shih, C., Rhodes, S. D., Armstrong, A. E., Wolters, P. L., Dombi, E., . . . Clapp, D. W. (2021). Cabozantinib for neurofibromatosis type 1-related plexiform neurofibromas: A phase 2 trial. Nat Med.
Citação norma ChicagoFisher, Michael J., et al. "Cabozantinib for Neurofibromatosis Type 1-related Plexiform Neurofibromas: A Phase 2 Trial." Nat Med 2021.
MLA CitationFisher, Michael J., et al. "Cabozantinib for Neurofibromatosis Type 1-related Plexiform Neurofibromas: A Phase 2 Trial." Nat Med 2021.
Advarsel: Disse citationer er muligvist ikke 100% nøjagtige.